Jul 21, 2022 9:00am EDT 22nd Century Announces $35 Million Registered Direct Offering Priced Above Market under Nasdaq Rules
Jun 22, 2022 9:25am EDT 22nd Century Group (Nasdaq: XXII) Supports Federal Proposal to Require Less Nicotine in All U.S. Cigarettes
May 27, 2022 9:25am EDT 22nd Century Group (Nasdaq: XXII) to Participate in LD Micro, Roth Capital Investor Meetings
May 23, 2022 9:25am EDT 22nd Century Group (Nasdaq: XXII) Announces John J. Miller Joins Its Tobacco Business
May 18, 2022 4:30pm EDT 22nd Century Group (Nasdaq: XXII) Begins Integration of GVB Biopharma, Creating a Complete, Robust Hemp/Cannabis Platform
May 13, 2022 9:16am EDT 22nd Century Group (Nasdaq: XXII) Acquires GVB Biopharma, a Leading Hemp/Cannabis Company
May 05, 2022 6:00am EDT 22nd Century Group (Nasdaq: XXII) Reports Business Highlights and Financial Results for the First Quarter 2022
Apr 29, 2022 9:30am EDT 22nd Century Group (Nasdaq: XXII) Expects VLN® Menthol King Reduced Nicotine Cigarettes To Be Exempted From FDA’s Proposed Ban on Menthol Cigarettes
